In reply
- PMID: 25838025
- PMCID: PMC4395765
- DOI: 10.3238/arztebl.2015.0210
In reply
Comment on
-
The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.Dtsch Arztebl Int. 2014 Sep 1;111(35-36):584-91. doi: 10.3238/arztebl.2014.0584. Dtsch Arztebl Int. 2014. PMID: 25249360 Free PMC article.
-
Unethical approach.Dtsch Arztebl Int. 2015 Mar 20;112(12):209. doi: 10.3238/arztebl.2015.0209a. Dtsch Arztebl Int. 2015. PMID: 25838023 Free PMC article. No abstract available.
-
Questionable pooling of data.Dtsch Arztebl Int. 2015 Mar 20;112(12):209-10. doi: 10.3238/arztebl.2015.0209b. Dtsch Arztebl Int. 2015. PMID: 25838024 Free PMC article. No abstract available.
References
-
- Munoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102:325–339. - PubMed
-
- De Carvalho N, Teixeira J, Roteli-Martins CM, Naud P, De Borba P, Zahaf T, et al. Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine. 2010;28:6247–6255. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical